Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Quality summit for the pharma industry
Quality summit for the pharma industry
BusinessLine

The two-day 11th Global Pharmaceutical Quality Summit, organised by the Indian Pharmaceutical Alliance, kicks off today in Mumbai. The industry conclave will be attended by drug regulatory representatives from multiple countries. There will be…

fool.com - Reuben Gregg Brewer - Novartis: This Big Pharma Giant Could Be a Sleep-at-Night Core Holding for Decades
Novartis: This Big Pharma Giant Could Be a Sleep-at-Night Core Holding for Decades
The Motley Fool

Novartis (NVS 0.76%) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas are extensive, spanning oncology, immunology, neuroscience, respiratory care, and cardiovascular, renal, and metabolic diseases.

statnews.com - Ed Silverman - Pharmalittle: We're reading about pharma lobbying, a disappointing Novo clinical trial, and much more
Pharmalittle: We're reading about pharma lobbying, a disappointing Novo clinical trial, and much more
STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned. Settling in may be a little more…

marketbeat.com - Vanguard Group Inc. Acquires 347,074 Shares of BridgeBio Pharma, Inc. $BBIO
Vanguard Group Inc. Acquires 347,074 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Vanguard Group Inc. lifted its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 2.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 16,832,059 shares of the company's stock after purchasing…

marketbeat.com - Tredje AP fonden Sells 39,546 Shares of Royalty Pharma PLC $RPRX
Tredje AP fonden Sells 39,546 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Tredje AP fonden lessened its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 51.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned…

thehindu.com - Reuters - India's drug regulator inspected 90% of cough syrup makers, found lapses, official says
India's drug regulator inspected 90% of cough syrup makers, found lapses, official says
The Hindu

India's drug regulator has inspected nearly 90% of ​the country's cough syrup makers and found compliance lapses, its ⁠chief said on Monday (January 23, 2026), amid heightened scrutiny after India-made syrups were linked to the deaths…

thenews.com.pk - Hafsa Naeem Baig - UK seeks 'best possible deal' with US as tariff threat looms
UK seeks 'best possible deal' with US as tariff threat looms
The News International

The UK government is in talks with the U.S. over the ‘best possible deal' for British firms amid the higher tariffs threat. High-level talks with the U.S. administration over the threat of increased tariffs are under way as the business…

globenewswire.com - Artios Pharma - Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer
Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer
GlobeNewswire

U.S. Fast Track designation of ART6043 underpinned by promising clinical data to date and high unmet need in gBRCA-mutated HER2-negative breast cancer Artios is launching a global randomized Phase 2 study to evaluate ART6043 in patients with…

fool.com - Adria Cimino - 3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds
3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds
The Motley Fool

The weight loss drug market has been one key focus for investors in recent years. This is because demand has been incredibly high, driving blockbuster revenue for companies making such products -- here, I'm talking about pharma giants Eli Lilly and…

thehindu.com - Siddharth Kumar Singh - Hyderabad airport contributes ₹68,000 crore to Telangana economy
Hyderabad airport contributes ₹68,000 crore to Telangana economy
The Hindu

Hyderabad's Rajiv Gandhi International Airport (RGIA) has evolved into one of Telangana's most significant economic drivers, contributing nearly ₹68,000 crore in gross value added (GVA) and supporting about 3.5 lakh jobs through direct…

thehindubusinessline.com - Corporate travel gains momentum as companies tap new markets
Corporate travel gains momentum as companies tap new markets
BusinessLine

Corporate travel is gaining momentum as companies explore new markets, according to travel companies. While there is no let-up in sentiment, companies are exercising sharper controls through advance booking mandates and closer monitoring of travel…

swissinfo.ch - swissinfo.ch - Basel Carnival kicks off with traditional 'Morgestraich'
Basel Carnival kicks off with traditional 'Morgestraich'
www.swissinfo.ch

Tracking down the Iran talks in Geneva Read more: Tracking down the Iran talks in Geneva Could direct democracy trip up Swiss trade deals? Read more: Could direct democracy trip up Swiss trade deals? Where UN Special Rapporteur sees freedom of…

cityam.com - Felix Armstrong - Novo Nordisk shares tumble after drug trial falls short
Novo Nordisk shares tumble after drug trial falls short
City AM

Shares in Danish drug giant Novo Nordisk have shed more than a sixth of their value after poor drug trial results sparked an investor selloff. The firm behind weight-loss drugs Ozempic and Wegovy saw its shares tumble by 16.7 per cent to 257.23…

pharmaceutical-technology.com - Annabel Kartal Allen - Novo Nordisk flags board members for re-election amid restructuring efforts
Novo Nordisk flags board members for re-election amid restructuring efforts
Pharmaceutical Technology

In a bid to regain operational stability, Novo Nordisk's Board of Directors has nominated two new members to join the committee, which has been undergoing a revamp in recent months. Jan van de Winkel and Ramona Sequeira would both serve a one-year…

axios.com - Maya Goldman - HHS takes another swing at drug discount overhaul
HHS takes another swing at drug discount overhaul
Axios

The Trump administration is doubling down on efforts to revamp the federal discount drug program — a major flashpoint between Big Pharma and hospitals. Why it matters: The so-called 340B program has been mired in litigation, most recently…

Receive a Daily briefing on Pharma Industry News

Get Started